GenomiCare Partners With N-Of-One To Provide High-Quality Clinical Interpretation For Comprehensive Next-Generation Sequencing Tests In China

LEXINGTON, Mass. & SHANGHAI--(BUSINESS WIRE)--N-of-One, Inc., the global leader in clinical interpretation for precision medicine in oncology, and GenomiCare Biotechnology, a fast-growing precision medicine services company headquartered in Shanghai, China, today announced a signed agreement for N-of-One to provide clinical interpretation for GenomiCare’s comprehensive oncology panels. Financial terms of the agreement are not disclosed.

Help employers find you! Check out all the jobs and post your resume.